Cell Dissociation Market to Reach USD 1,347 Million by 2030 Amid Rising Stem Cell ResearchPosted by Aryan on September 3rd, 2024 The cell dissociation market is set to grow at a remarkable rate of 18.8%, reaching USD 1,347 million by 2030. This growth is largely driven by the increasing awareness of stem cell research, advancements in technology, and the rising demand for monoclonal antibodies and personalized medicine. Additionally, the prevalence of communicable and chronic diseases, the growing number of pharmaceutical and biotech companies, and increased government funding for new drug development are further boosting the demand for cell dissociation. In 2022, the enzymatic dissociation segment led the market, holding over 48% of the revenue share. This dominance is due to its superior efficiency, gentle nature, and widespread use in veterinary medicine, biotech processes, and tissue culture laboratories. Among enzymatic dissociation products, collagenases are particularly popular, given their numerous applications such as burn and wound healing, debridement, glaucoma, and keloid treatment. Collagenases are present in various organisms and animal cells and are widely accessible. The rising incidence of chronic diseases, especially cancer, ongoing advancements in the pharmaceutical and biotech sectors, strategic acquisitions and partnerships by key players, and strong trends in research and development investments in life sciences and academia are further propelling the industry forward. For instance, government reports indicate that chronic diseases account for approximately 75% of global deaths, with around 85% of premature deaths occurring in low- and middle-income countries. Chronic respiratory diseases affect nearly 4 million people, while 2 million suffer from diabetes. This growing burden of chronic diseases is driving industry growth. Browse detailed report analysis on "Cell Dissociation Market Size, Share and Forecast Report, 2030" In terms of tissue type, connective tissue leads the cell dissociation market due to the rising incidence of cancer, which increases the need for single-cell-based research. In 2020, government data revealed that about 1 in 6 deaths worldwide was due to cancer. Connective tissue, composed of extracellular fibers and cells, primarily contains collagen. The collagenase enzyme is used in the isolation of various cell types, including epithelial, endothelial, and adrenal tissues. It also plays a crucial role in isolating cell types such as adipocytes, hepatocytes, and cardiomyocytes and is used in treating mammary and other soft tissues. Pharmaceutical and biotech companies dominate the industry, driven by their increasing investments in research and development across multiple therapeutic areas for new drug launches. Furthermore, investments in research activities such as clinical trials, efficacy studies, and toxicity studies have also risen, fueling the demand for dissociation products used in cell isolation from key tissues in pharma and biotech organizations. The global focus on personalized medicine continues to drive demand for cell dissociation, a trend that is expected to persist in the coming years. About P&S Intelligence P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges. Contact: Like it? Share it! More by this author |